These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8338875)

  • 1. Mdx transgenic mouse: restoration of recombinant dystrophin to the dystrophic muscle.
    Lee CC; Pons F; Jones PG; Bies RD; Schlang AM; Leger JJ; Caskey CT
    Hum Gene Ther; 1993 Jun; 4(3):273-81. PubMed ID: 8338875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
    Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
    Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B
    FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
    Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
    Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice.
    Wells DJ; Wells KE; Walsh FS; Davies KE; Goldspink G; Love DR; Chan-Thomas P; Dunckley MG; Piper T; Dickson G
    Hum Mol Genet; 1992 Apr; 1(1):35-40. PubMed ID: 1301134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
    Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
    Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study.
    Nahirney PC; Ovalle WK
    Anat Rec; 1993 Apr; 235(4):501-10. PubMed ID: 8465985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.
    Danko I; Chapman V; Wolff JA
    Pediatr Res; 1992 Jul; 32(1):128-31. PubMed ID: 1635838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.
    Denetclaw WF; Hopf FW; Cox GA; Chamberlain JS; Steinhardt RA
    Mol Biol Cell; 1994 Oct; 5(10):1159-67. PubMed ID: 7865881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles.
    Pichavant C; Chapdelaine P; Cerri DG; Bizario JC; Tremblay JP
    Hum Gene Ther; 2010 Nov; 21(11):1591-601. PubMed ID: 20553115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
    Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
    Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
    Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
    Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGF-receptor concentration is elevated in regenerative muscle fibers in dystrophin-deficient muscle.
    Tidball JG; Spencer MJ; St Pierre BA
    Exp Cell Res; 1992 Nov; 203(1):141-9. PubMed ID: 1426037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
    Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform.
    Rafael JA; Sunada Y; Cole NM; Campbell KP; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1994 Oct; 3(10):1725-33. PubMed ID: 7849695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
    Wilton SD; Dye DE; Blechynden LM; Laing NG
    Neuromuscul Disord; 1997 Jul; 7(5):329-35. PubMed ID: 9267847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.